Information about SaveRxCanada.to
List of countries where we can ship Letairis:
Latest news releases on Letairis:
Find out about Letairis as a treatment option. See study results, access resources, and more. View Important Safety Info, including important warnings.
Letairis is used to treat pulmonary arterial hypertension (PAH). Learn about side effects, interactions and indications.
Learn more about pulmonary arterial hypertension (PAH), how it’s diagnosed, its symptoms, WHO Functional Classes, and more.
2 FULL PRESCRIBING INFORMATION WARNING: EMBRYO-FETAL TOXICITY Do not administer Letairis to a pregnant female because it may cause fetal harm.
THE AMBITION TRIAL Expert Presentation of the Use of Initial Combination Therapy in Pulmonary Arterial Hypertension (PAH) The AMBITION trial was the first and only ...
Download Letairis REMS Materials. In order to ensure that Letairis is prescribed and taken safely, Gilead has worked with the FDA to develop materials for the ...
The Letairis Risk Evaluation and Mitigation Strategy (REMS) Program A Risk Evaluation and Mitigation Strategy is a strategy to manage known or potential serious risks ...
U.S. Food and Drug Administration Approves New Treatment Combination of Gilead’s Letairis® with Tadalafil for Pulmonary Arterial Hypertension (WHO Group 1)
The U.S. Food and Drug Administration (FDA) is removing the warning related to liver injury from the boxed warning of the Letairis (ambrisentan) tablet label.
n engl j med 373;9 nejm.orgAugust 27, 2015 835 Ambrisentan–Tadalafil in Pulmonary Arterial Hypertension R egardless of the initiating trig-ger, pulmonary arterial ...